|
|
Article: RADIATION SICKNESS DRUG DEVELOPED.(News)
- Article from:
- The Cincinnati Post (Cincinnati, OH)
- Article date:
- May 19, 2003
CopyrightCOPYRIGHT 2003 The Cincinnati Post. All rights reserved. Reproduced with the permission of Dialog LLC by Gale Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SAN DIEGO -- U.S. military officials are expressing enthusiasm about an experimental drug -- HE-2100 -- that they say could protect the health of troops, police officers and emergency medical personnel who respond to terrorist attacks involving nuclear weapons or radiation-spewing "dirty bombs."
The drug being developed by Hollis-Eden Pharmaceuticals Inc. of San Diego appears to offer ...
Related newspaper, magazine, and journal articles:
|
|
Article: ImmuneRegen BioSciences Get Critical Guidance from FDA and ...
PR Newswire;
March 17, 2004 ;
700+ words
... ... compound Homspera in treating acute radiation sickness (ARS). This meeting was a direct ... efficacy of Homspera in treating acute radiation sickness, which can occur from any number ... approval for Homspera in treating acute radiation sickness," explains Michael K. Wilhelm ...
|
|